• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600

Print

Polar Capital Biotech I Inc

Specialist
Price: $84.08|Change: 2.38 (-2.75%)

Pricing frequency 

Daily

Dealing cut off time 

13:45

Type 

OEIC

Yield 

–

NAV 

$84.08

Income frequency 

Annually

Ongoing charge 

1.1%

Latest actual NAV date 

20-08-2026

ISIN 

IE00B42Z4531

UCITS 

Yes

This fund can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Before investing please read:

Key Information Document (KID/KIID)/Product Summary

Growth of 10k

Asset allocation

Top 10 holdings

Holdings 30/06/2026% of assets
Rhythm Pharmaceuticals Inc4.58
Arcutis Biotherapeutics Inc Ordinary Shares4.30
argenx SE4.28
Ascendis Pharma AS4.08
Xenon Pharmaceuticals Inc3.88
Alnylam Pharmaceuticals Inc3.61
AstraZeneca PLC3.49
Enliven Therapeutics Inc3.40
Amgen Inc3.32
Madrigal Pharmaceuticals Inc3.25

Performance 31/07/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

Total return (%)
Fund- 2.75
Category-
More...

Investment objective

The investment objective of the Fund is to achieve long term capital appreciation. The Fund will seek to achieve its investment objective by investing in a globally diversified portfolio of biotechnology, diagnostics and life sciences tools companies.

Sustainability Label

This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.

Morningstar ratingTM

Morningstar sustainability ratingTM

Morningstar Medalist RatingTM

  Morningstar analyst document

  Morningstar report document

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.